Puma Biotechnology, Inc.PBYINASDAQ
Loading
EPS Diluted Over TimeStrong
Percentile Rank93
3Y CAGR+210.8%
Studio
Year-over-Year Change

Diluted earnings per share

3Y CAGR
+210.8%/yr
Annual compound
Percentile
P93
Near historical high
vs 3Y Ago
30x
Strong expansion
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM0.61-1.7%
20240.62+37.8%
20230.45+2116.7%
20220.02+102.8%
2021-0.72+52.6%
2020-1.52+28.6%
2019-2.13+28.8%
2018-2.99+62.0%
2017-7.86+5.2%
2016-8.29-